Page last updated: 2024-08-17

dimethyl sulfone and Metabolic Diseases

dimethyl sulfone has been researched along with Metabolic Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chung, M; Gaspar, JM; Jung, HJ; Kang, MC; Kim, YB; Lee, SH; Macedo, MP; Mantzoros, C; Park, KS; Park, SY; Seo, JA; Sousa-Lima, I1
Engelke, UF; Loss, S; Moskau, D; Mudd, SH; Tangerman, A; Wevers, RA; Willemsen, MA1

Trials

1 trial(s) available for dimethyl sulfone and Metabolic Diseases

ArticleYear
Dimethyl sulfone in human cerebrospinal fluid and blood plasma confirmed by one-dimensional (1)H and two-dimensional (1)H-(13)C NMR.
    NMR in biomedicine, 2005, Volume: 18, Issue:5

    Topics: Adolescent; Adult; Aged; Biomarkers; Carbon Isotopes; Child; Child, Preschool; Dimethyl Sulfoxide; Female; Humans; Infant; Infant, Newborn; Magnetic Resonance Spectroscopy; Male; Metabolic Diseases; Middle Aged; Nervous System Diseases; Protons; Sulfones

2005

Other Studies

1 other study(ies) available for dimethyl sulfone and Metabolic Diseases

ArticleYear
Methylsulfonylmethane (MSM), an organosulfur compound, is effective against obesity-induced metabolic disorders in mice.
    Metabolism: clinical and experimental, 2016, Volume: 65, Issue:10

    Topics: 3T3-L1 Cells; Animals; Anti-Obesity Agents; B-Lymphocytes; Blood Glucose; Cholesterol; Diet, High-Fat; Dimethyl Sulfoxide; Femur; Gene Expression; Insulin Resistance; Lipid Metabolism; Liver; Male; Metabolic Diseases; Mice; Mice, Inbred C57BL; Mice, Obese; Myeloid Cells; Obesity; Sulfones; Triglycerides

2016